NCT01843985

Brief Summary

Patients diagnosed with Stage IV cancer (solid tumors only) are evaluated to determine whether they are candidates for traditional chemotherapy. If eligible, patients are offered traditional chemotherapy, low-dose chemotherapy, or palliative care. If ineligible, patients are offered low-dose chemotherapy or palliative care. Patients will be monitored for 5 years and survival data recorded.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2013

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

April 27, 2013

Completed
4 days until next milestone

First Posted

Study publicly available on registry

May 1, 2013

Completed
1 month until next milestone

Study Start

First participant enrolled

June 1, 2013

Completed
5.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2018

Completed
Last Updated

May 1, 2013

Status Verified

April 1, 2013

Enrollment Period

5.5 years

First QC Date

April 27, 2013

Last Update Submit

April 27, 2013

Conditions

Stage IV Cancer (Solid Tumors Only)Survival

Keywords

Stage IV cancerSurvival

Outcome Measures

Primary Outcomes (1)

  • survival

    months 1, 2, 3, 4, 6, 9, 12, 18, 24, 36, 48, 60

Study Arms (5)

1. Eligible RCT/Elect RCT

Eligible for regular chemotherapy, elects and receives regular chemotherapy

2. Eligible RCT/Elect LDC

Eligible for regular chemotherapy, elects and receives low-dose chemotherapy

3. Eligible RCT/Elect PCO

Eligible for regular chemotherapy, elects and receives palliative care only

4. Ineligible RCT/Elect LDC

Ineligible for regular chemotherapy, elects and receives low-dose chemotherapy

5. Ineligible RCT/Elect PCO

Ineligible for regular chemotherapy, elects and receives palliative care only

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

primary care clinic

You may qualify if:

  • Presenting with Stage IV cancer (solid tumors only)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Yang Ling Demonstration Zone Hospital

Yangling, Shaanxi, China

Location

MeSH Terms

Conditions

Neoplasms

Central Study Contacts

gary smith

CONTACT

5207492035garylsmith2@msn.com

Study Design

Study Type
observational
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 27, 2013

First Posted

May 1, 2013

Study Start

June 1, 2013

Primary Completion

December 1, 2018

Study Completion

December 1, 2018

Last Updated

May 1, 2013

Record last verified: 2013-04

Locations

CN(1)